26 May 2023
A study published in Cell Metabolism has suggested that the commonly used medicine for type 2 diabetes, canagliflozin, may be repurposed to treat T-cell driven autoimmunity as the medicine reduces T-cell activation. The scientists hope to move the study to clinical trials.
Study using twins sees cardiovascular improvements with vegan diet
07 Dec 2023
Menarche at early age linked to increased diabetes risk
07 Dec 2023
In utero exposure to Covid-19 associated with preterm birth
07 Dec 2023
Type 2 diabetes risk may be reduced with fast walking
01 Dec 2023
Pomegranate consumption linked to prevention of metabolic disorders
01 Dec 2023